Infographic: A randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia: the RADIANCE study. (2023)

First Author: Yusuf IH
Attributed to:  Development of AAV gene therapy for blindness caused by cone-rod dystrophy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41433-023-02392-4

PubMed Identifier: 37085717

Publication URI: http://europepmc.org/abstract/MED/37085717

Type: Journal Article/Review

Parent Publication: Eye (London, England)

ISSN: 0950-222X